Dietary Supplement Urolithin A Linked to Increased Brain Blood Flow in Trial
A recent randomized clinical trial suggests that the supplement urolithin A may increase cerebral blood flow during cognitive tasks in middle-aged adults with obesity. However, researchers noted that the small, short-term study did not show immediate improvements in memory test scores.
🥗NutritionPhoto: Medical Xpress
Key points
- Urolithin A increased brain blood flow during memory tasks in a trial of 50 adults.
- The four-week study did not show significant improvements in actual memory test scores.
- Researchers stress that longer and larger trials are needed to confirm any health benefits.
A dietary supplement known as urolithin A has been found to boost blood circulation to the brain during cognitive exertion among middle-aged adults with obesity, according to a University of Oklahoma study published in JAMA Network Open. Researchers investigated the compound to see if it could counteract vascular changes associated with obesity that typically impact bodily circulation, including blood flow to the brain.
The randomized clinical trial tracked 50 participants aged 40 to 64 who consumed either 1,000 milligrams of urolithin A daily or a placebo over a four-week period. Scientists observed that individuals taking the supplement experienced greater blood flow to the brain—specifically in the left dorsolateral prefrontal cortex, an area vital for working memory—while engaging in a demanding memory task. Despite the enhanced cerebrovascular response, the trial did not reveal significant changes in arm blood vessel function or measurable gains in cognitive performance during the tests.
Urolithin A is naturally generated when specific gut microbes process compounds found in foods such as walnuts, pomegranates, and strawberries. Natural production levels differ among individuals and tend to decline alongside aging and higher body mass index, though the compound is also sold in supplement form. While the substance was well-tolerated by participants, investigators emphasized that the findings stem from a relatively small, single-site trial.
What to know: While urolithin A may support healthy brain blood flow during mental activity, more extensive and prolonged studies are required to determine if these vascular changes translate into long-term cognitive benefits. Always consult a healthcare professional before altering your supplement regimen or making major health decisions.
Source Medical Xpress — medicalxpress.com/news/2026-11-clinical-trial-explores-potential-brain.… ↗
Read next
🧠Mind & Mental HealthStudy Finds Mixed Clinical Alignment in Reddit Mental Health Advice
A new Flinders University study reveals that while popular peer advice on Reddit often recommends professional help for depression and anxiety, some responses lack the ne…
❤️Conditions & CarePapua New Guinean Tree Compound Shows Potential in Motor Neuron Disease Study
Researchers at the University of Wollongong identified a natural compound from a rainforest tree that protected motor neurons against degeneration in laboratory tests.
🔬ResearchVirtual Reality Lowers Pain and Anxiety in Pediatric Emergency Care, Study Finds
A new systematic review and meta-analysis suggests that virtual reality technology can successfully decrease pain and anxiety for children undergoing procedures in hospit…
🏥Public HealthNew Parents with Intellectual Disabilities Face Significantly Higher Rates of Psychiatric Hospitalizations
Recent Australian research reveals that new parents with intellectual disabilities experience drastically elevated rates of emergency room visits and hospital admissions …
🔬ResearchStudy Highlights Emotional, Social, and Spiritual Needs in Pediatric Palliative Care
A systematic review published in Palliative Medicine reveals that children receiving end-of-life care require psychological security, maintained social connections, and w…
🔬ResearchType 2 Diabetes Linked to a 53% Higher Risk of Alzheimer's Disease, Study Finds
A comprehensive meta-analysis led by Curtin University researchers indicates that individuals with type 2 diabetes face a substantially elevated relative risk of developi…